Waldencast SPAC Presentation Deck slide image

Waldencast SPAC Presentation Deck

DBAG Robust portfolio of highly-effective science-based products CORE BUSINESS (90%+ SALES) MEDICAL 3110 FE HELLE Transformational skincare products formulated to brighten, nourish, protect and enhance skin tone and texture ~25% Revenue in 2020 generated from prescription solutions' $22-$471 Product price rangel.2 *OBAGI information; ² Refers to MSRP, 3 Revenue from Obagi Clinical OBAGI MACAR CONSUMER Accessible, dermatologist-backed brightening, and minimizing fine lines products designed for retexturizing, & wrinkles Launched in 2018 $7mm 2021E revenues NILINE $38-$145 Product price range¹, 2 GROWTH OPPORTUNITIES DEVICES First professional-use device designed by Obagi for in-clinic use Launched in Q2 2021 DEN PROFESSIONAL SPA High-quality products designed for customers that want sensory and high performance "clinical spa" experience Launching in Q4 2021 20
View entire presentation